Systems For LNP Production: From Early Stage To Commercial Scale

Moving a lipid nanoparticle process from screening to commercial throughput raises a persistent question: do particle characteristics hold when the hardware changes? KNAUER's answer centers on impingement jet mixing, applied across its NanoScaler, NanoProducer and customized systems.

This brochure follows that approach from early formulation work through clinical and commercial production, with scale-up data from Acuitas, application work from Curapath and a customer perspective from eTheRNA. Software, GMP-ready documentation, partner support and training complete the picture. Download the brochure below to explore the systems and the evidence behind them.